Kendell Clement

Centre for Addiction and Mental Health — Canada

Biochemistry, Genetics and Molecular Biology · Life Sciences

34h-index8.7kcitations163works2.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CRISPR and Genetic Engineering(44), Chronic Lymphocytic Leukemia Research(42), Cytokine Signaling Pathways and Interactions(23), Acute Lymphoblastic Leukemia research(22), Epigenetics and DNA Methylation(17)

Publications163 total

Immune checkpoint expression in mucosal-associated invariant T cells is stimulus-dependent
Journal of Leukocyte Biology·2025Open Access
Supplementary Tables from <i>In Vivo</i> Modeling of CLL Transformation to Richter Syndrome Reveals Convergent Evolutionary Paths and Therapeutic Vulnerabilities
2025Open Access
Supplementary Table S9 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States
2025Open Access
Supplementary Table S3 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States
2025Open Access
Supplementary Table S8 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States
2025Open Access
Supplementary Figures from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States
2025Open Access
Supplementary Table S5 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States
2025Open Access
Supplementary Table S7 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States
2025Open Access
Supplementary Table S6 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States
2025Open Access
Supplementary Figures from <i>In Vivo</i> Modeling of CLL Transformation to Richter Syndrome Reveals Convergent Evolutionary Paths and Therapeutic Vulnerabilities
2025Open Access
Supplementary Table S2 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States
2025Open Access
Supplementary Table S4 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States
2025Open Access
Supplementary Table S1 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States
2025Open Access
M30. TRANSLATING GENOME-WIDE SIGNIFICANCE FOR LOW-FREQUENCY VARIANTS IMPROVES LOCUS DISCOVERY AND BIOLOGICAL INSIGHTS
European Neuropsychopharmacology·2025
Endothelial Cell Genetics in Carotid Artery Atherosclerosis and Intracranial Atherosclerosis: A Systematic Review
Stroke Vascular and Interventional Neurology·2025Open Access
Protocol for permanent gene repression by CRISPR-adenine base editing of promoter CCAAT motifs
STAR Protocols·2025Open Access
A Singular Base Editing Platform for Polyfunctional Multiplex Engineering of Immune Cells
2025· 1 citedOpen Access
KDM4C inhibition blocks tumor growth in basal breast cancer by promoting cathepsin L-mediated histone H3 cleavage
Nature Genetics·2025· 4 citedOpen Access
Precision enhancement of CAR-NK cells through non-viral engineering and highly multiplexed base editing
Journal for ImmunoTherapy of Cancer·2025· 19 citedOpen Access
Genetic and training adaptations in the Haenyeo divers of Jeju, Korea
Cell Reports·2025· 4 citedOpen Access
page 1 of 9Next →

Frequent Co-authors

Alexander Meissner(24), Luca Pinello(22), J. Keith Joung(17), Hongcang Gu(16), Andreas Gnirke(15), Jonathan Y. Hsu(8), Martin J. Aryee(8), Catherine J. Wu(8), Daniel E. Bauer(7), Michael J. Ziller(7), Donna Neuberg(7), Konrad Hochedlinger(7), Ramona Pop(5), Peter Boyle(5), Sara P. Garcia(5), Aaron J. Huebner(5), Arman W. Mohammad(5), Zachary D. Smith(5), Jocelyn Charlton(5), Vikram Pattanayak(5)